Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists - PubMed (original) (raw)

Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists

S C Bischoff et al. J Exp Med. 1990.

Abstract

Human interleukin 5 (IL-5), known as a selective colony-stimulating factor of the eosinophil lineage and activator of mature eosinophils, also profoundly influences the mediator release profile of human basophils. IL-5 by itself triggers neither granule release nor de novo synthesis of lipid mediators. However, at low concentrations (0.1-10 ng/ml), IL-5 rapidly primes basophils for enhanced histamine release and leukotriene C4 (LTC4) generation in response to all established basophil agonists. LTC4 generation is more strongly affected by IL-5 than histamine release. In particular, IL-5 renders basophils capable of producing large quantities of LTC4 in response to C5a, which, without the cytokine, induces histamine release only. Finally, IL-5 renders basophils responsive to agonists (neutrophil-activating peptide 1 and C3a), which are otherwise inefficient triggers for basophil mediator release. The effects are similar to the recently established bioactivity of IL-3 on basophils, with the exception of its influence on IgE-dependent basophil activation, which is less pronounced. Thus, IL-5 strongly modulates the function not only of eosinophils but also of basophils, the two major effector leukocyte types involved in allergic inflammatory processes, e.g., in asthma.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Blood. 1985 Aug;66(2):312-8 - PubMed
    1. J Immunol. 1990 Feb 15;144(4):1345-52 - PubMed
    1. J Exp Med. 1988 Apr 1;167(4):1281-95 - PubMed
    1. J Exp Med. 1988 Jan 1;167(1):219-24 - PubMed
    1. J Exp Med. 1986 Jul 1;164(1):165-79 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources